Qingbin Cui

Also affiliated with Sun Yat-sen University, Toledo Clinic Cancer Center, Sun Yat-sen University Cancer Center, University of Toledo, Guangzhou Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance”.

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance

Frontiers in Oncology(2020)10.3389/fonc.2020.01219

N/A

0.792DataRank · unranked

22 citations

Xuan-Yu Chen, Xing-Duo Dong, Jing‐Quan Wang, Weiguo Feng, Qiu‐Xu Teng +5 more

Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c01130

N/A

0.464DataRank · unranked

21 citations

Caoqinglong Huang, Jingyuan Liu, Jian‐Ting Zhang, Qingbin Cui

Targeting fatty acid synthase for cancer drug discovery: Retrospective analyses and outlook

Pharmacological Reviews(2025)10.1016/j.pharmr.2025.100105

N/A

0.208DataRank · unranked

3 citations

Sophia Josephraj, Boqing Gu, Jingyuan Liu, Jian‐Ting Zhang, Qingbin Cui

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter

Frontiers in Oncology(2020)10.3389/fonc.2020.574861

N/A

0DataRank · unranked

35 citations

Pranav Gupta, Qingbin Cui, Yunali V. Ashar, Zhuo‐Xun Wu, Leli Zeng +6 more

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00228

N/A

0DataRank · unranked

32 citations

Jing‐Quan Wang, Chao‐Yun Cai, Qingbin Cui, Yuqi Yang, Zhuo‐Xun Wu +6 more

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.601400

N/A

0DataRank · unranked

32 citations

Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Han Fu +5 more

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

Cancers(2020)10.3390/cancers12020466

N/A

0DataRank · unranked

54 citations

Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui +5 more

A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells

Bioorganic & Medicinal Chemistry(2022)10.1016/j.bmc.2022.116761

N/A

0DataRank · unranked

20 citations

Qingbin Cui, Kwaku Kyei‐Baffour, Sophia Josephraj, Caoqinglong Huang, Zizheng Dong +4 more

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1235285

N/A

0DataRank · unranked

28 citations

Qingbin Cui, Jing‐Quan Wang, Charles R. Ashby, Yanchun Chen, Zhixin Shen +2 more

Targeting fatty acid synthase to overcome PARP inhibitor resistance and to create an artificial synthetic lethality for triple-negative breast cancer

Genes & Diseases(2025)10.1016/j.gendis.2025.101817

N/A

0DataRank · unranked

5 citations

Chao J. Wang, Qingbin Cui, Zizheng Dong, Jingyuan Liu, Jian‐Ting Zhang +1 more

Design, synthesis, and evaluation of quinoxaline-based survivin inhibitors for castration-resistant prostate cancer

Bioorganic Chemistry(2025)10.1016/j.bioorg.2025.108714

N/A

0DataRank · unranked

3 citations

Caoqinglong Huang, Xunzhen Zheng, Zizheng Dong, Jing-Yuan Liu, Jian‐Ting Zhang +1 more

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells

Frontiers in Pharmacology(2022)10.3389/fphar.2022.843829

N/A

0DataRank · unranked

27 citations

Meng Zhang, Chao‐Yun Cai, Qiu‐Xu Teng, Jing‐Quan Wang, Yige Fu +5 more

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00955

N/A

0DataRank · unranked

50 citations

Meng Zhang, Zhuo‐Xun Wu, Jing‐Quan Wang, Xing-Duo Dong, Yuqi Yang +5 more

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Cancer Communications(2020)10.1002/cac2.12040

N/A

0DataRank · unranked

40 citations

Ning Ji, Chao‐Yun Cai, Jing‐Quan Wang, Zi‐Ning Lei, Qiu‐Xu Teng +5 more